Sentinel - Triaging Acute Breathlessness Using Multi-Modal Biomarkers

NCT05304494 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2022-05-13

No results posted yet for this study

Summary

The Sentinel-001 study aims to identify a combination of biomarkers suitable for triage of breathlessness.

Conditions

Interventions

OTHER

Biomarker tests for participant profiling

Combination of digital and physical tests to objectify measures relevant for breathlessness

Sponsors & Collaborators

  • Sanome

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-31
Primary Completion
2024-03-31
Completion
2024-03-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05304494 on ClinicalTrials.gov